CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
about
Clinical development of gene therapy: results and lessons from recent successesRegulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in TransplantationFriend or foe: the dichotomous impact of T cells on neuro-de/re-generation during agingProtective and detrimental roles for regulatory T cells in a viral model for multiple sclerosisAlloantigen-specific regulatory T cells generated with a chimeric antigen receptorAdoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.Development of Gene Transfer for Induction of Antigen-specific Tolerance.Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses.Screening and identification of human ZnT8-specific single-chain variable fragment (scFv) from type 1 diabetes phage display library.Controlled release strategies for modulating immune responses to promote tissue regenerationTargeting Treg signaling for the treatment of autoimmune diseasesThe role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitisTolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.Chromatin Remodeling Protein SMAR1 Is a Critical Regulator of T Helper Cell Differentiation and Inflammatory Diseases.Genetic Susceptibility to Multiple Sclerosis: The Role of FOXP3 Gene Polymorphism.T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.Regulatory T cells: tolerance induction in solid organ transplantation.In vivo induction of regulatory T cells for immune tolerance in hemophilia.Stabilizing human regulatory T cells for tolerance inducing immunotherapy.Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics.CAR T-Cell Therapy: Progress and Prospects.Cell-Based Therapies with T Regulatory Cells.How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.Regulatory T Cells: Central Concepts from Ontogeny to Therapy.Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis.In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.Antigen-specific immunotherapies in rheumatic diseases.The Role of the Ikaros Family of Transcription Factors in Regulatory T cell Development and Function.Expression and Function of the Cholinergic System in Immune Cells.Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of AsthmaTolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells.From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance.Therapeutic application of T regulatory cells in composite tissue allotransplantation.Engineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells.Posttransplant chimeric antigen receptor therapy.Engineering therapeutic T cells to suppress alloimmune responses using TCRs, CARs, or BARs.
P2860
Q26743393-93EEC685-2827-4A6F-B354-F0F3591D5A2BQ26784460-345E1E29-80E1-4E0B-B9BA-CE3C4A98A76DQ28077869-1670FF36-6324-48F8-952F-42C35E6DE171Q33901171-732F1266-FCA3-4894-A9E4-6B845725971BQ34046489-B9D4135C-0D07-4FBA-86FD-A107C38C10BAQ34540968-97259D07-09CF-42E2-B0A2-504BD3E50709Q34794525-55D0D04F-165C-4690-86AC-164852CFFCCDQ35080090-465F8B0B-958A-4CBF-94DC-228E79B631A7Q36043179-7D73E647-A246-4CE8-87AE-0A138BB0799AQ36307642-6FAE0B8C-DFD3-449D-94DE-184235EDEE73Q36372616-FAAC79DB-800E-47B9-9951-F87B764C09E3Q36640032-0903B855-650E-4591-A0F7-CDAD7F28A353Q37533397-B4E45BB0-10F2-43F3-A968-7D215633B602Q37632880-79582F38-8775-4A8E-966E-7ED832F367FAQ37725869-54C400B1-7B1B-4940-B697-1EE3010D086EQ38274179-54FB9A63-D8B1-4930-8670-9A873522A26CQ38303586-78708425-3025-4C6A-B8CE-37FD45ABD472Q38424224-40F927FB-35A0-44A1-9B9A-D4CB1084614AQ38557841-28093E5E-110C-4D32-B620-98137FC7D8D0Q38574966-44C6C0D7-78E5-4E1F-8165-D33FCC9C36DAQ38644779-DAFFF680-5B52-49C3-86EE-C8888F2ADEF9Q38741113-286731BE-CC69-4FC2-81D3-5EA0BC851BCEQ38741433-62D4CD37-E4FB-465B-88EE-152335ECD350Q38766028-3DB49DE7-D04B-491E-9124-B8456B4D1298Q38852283-5A41EBAA-AC12-41AF-8D5C-4833BCCF10F5Q38927531-5A9E43D5-51C0-417E-ADD1-1D0503D571AFQ39062014-D4AEA886-4547-40FA-A7E6-CAF396DEC7A1Q39158358-1D8DB5A6-5788-4256-A80D-2A60E49685F8Q39245827-F8F48B51-B9CB-4BD8-B42C-452EE179CBC8Q39246685-17EBCB59-4FF0-4E7D-A065-1436E47B79F5Q39431371-0B1BAB72-EF52-43EF-A212-90133FE32DCBQ40113685-1A212425-3DFC-48D5-B54B-42E7AAA9781EQ41440417-72691012-CEAF-47F5-B214-59484E50D935Q41684124-572431DD-1CA4-4512-9903-650B5859A934Q42157420-813CC847-0D79-4FFE-9ABD-C9C6D9F0295AQ45875104-8CC3C6BB-76A7-45BA-9905-86F5198257EEQ46772183-A4A48594-0F68-4198-95C6-0CB4316CFA98Q47150746-7E4CF2D5-7160-4B0F-A82C-684F8A904202Q47550219-EF621F89-D4F3-4FA7-BDC5-29F1E211E9A5Q52336320-7D0E2786-D850-42CA-90B6-4F9018B628D2
P2860
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CAR/FoxP3-engineered T regulat ...... EAE upon intranasal delivery.
@ast
CAR/FoxP3-engineered T regulat ...... EAE upon intranasal delivery.
@en
type
label
CAR/FoxP3-engineered T regulat ...... EAE upon intranasal delivery.
@ast
CAR/FoxP3-engineered T regulat ...... EAE upon intranasal delivery.
@en
prefLabel
CAR/FoxP3-engineered T regulat ...... EAE upon intranasal delivery.
@ast
CAR/FoxP3-engineered T regulat ...... EAE upon intranasal delivery.
@en
P2093
P2860
P50
P356
P1476
CAR/FoxP3-engineered T regulat ...... s EAE upon intranasal delivery
@en
P2093
Berith Nilsson
Binfeng Lu
Elena Piras
Magnus Essand
Moa Fransson
Peetra U Magnusson
Robert A Harris
P2860
P2888
P356
10.1186/1742-2094-9-112
P577
2012-05-30T00:00:00Z
P5875
P6179
1014964503